Clinical trial
A Phase 2, Open-label, Randomized Study to Evaluate GPRC5D-related Oral Events
NCT06500884 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Open-label, Randomized Study to Evaluate GPRC5D-related Oral Events
- Lead sponsor
- Janssen Research & Development, LLC
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 26, 2024
- Completion date
- May 30, 2030
- Enrollment
- 210 (estimated)
- Sites
- 38
Conditions
As the registry lists them; a condition with its own page is linked.